Yu‐Jing Zhang

机构：Sun Yat-sen University, First Affiliated Hospital of Xi'an Jiaotong University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-2659-6354

发表论文 41 篇 · 总被引 1117 次 · h-index 17

代表论文

• Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making (2020 · Leukemia · 被引 133)
• First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG (2020 · Blood Advances · 被引 60)
• Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma (2019 · JAMA Network Open · 被引 48)
• Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group (2018 · Blood Advances · 被引 34)
• Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (2020 · Leukemia · 被引 33)
• Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) (2019 · Aging · 被引 23)